Edward J Rebar

USPTO Granted Patents = 88 (Patent Applications = 19)

CIPO Patents = 17 (Patent Applications = 12)

EPO Patents = 19 (Patent Applications = 32)

Average Co-Inventor Count = 2.7

ph-index = 19

Forward Citations = 3,009(Granted Patents)

Forward Citations (Not Self Cited) = 2,472(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Cambridge, MA (US) (1998)
Berkeley, CA (US) (2002 - 2010)
El Cerrito, CA (US) (2003 - 2016)
San Francisco, CA (US) (2013 - 2021)
Richmond, CA (US) (2014 - 2024)
Brisbane, CA (US) (2023 - 2024)

Company Filing History:

44 out of 145

Sangamo Therapeutics, Inc.

patents

43 out of 160

Sangamo Biosciences, Inc.

patents

3 out of 5,450

The University of Texas System

patents

4. 2 out of 15,475

University of California

patents

5. 1 out of 8,373

Massachusetts Institute of Technology

patents

6. 1 out of 53

Chdi Foundation, Inc.

patents

where one patent can have more than one assignee

Years Active: 1998-2024

Loading Chart...

Areas of Expertise:

DNA-Binding Proteins

Gene Expression Regulation

Transgene Expression

Engineered Nucleases

Genome Engineering

Huntington's Disease Treatment

Lysosomal Storage Diseases

Zinc Finger Proteins

HLA Locus Modification

Trinucleotide Repeat Disorders

Targeted Disruption

TALE Proteins

88 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11920169 - Compositions for linking DNA-binding domains and cleavage domains (2024-03-05),

2. 11898158 - Methods and compositions for the treatment of lysosomal storage diseases (2024-02-13),

3. 11859190 - Methods and compositions for regulation of transgene expression (2024-01-02),

4. 11845965 - Regulation of gene expression using engineered nucleases (2023-12-19),

5. 11834686 - Engineered target specific base editors (2023-12-05),

6. 11827900 - Engineered target specific nucleases (2023-11-28),

7. 11723952 - Methods and compositions for treating Huntington's Disease (2023-08-15),

8. 11661612 - DNA-binding proteins and uses thereof (2023-05-30),

9. 11639504 - Methods and compositions for regulation of transgene expression (2023-05-02),

10. 11634463 - Methods and compositions for treating hemophilia (2023-04-25),

11. 11512287 - Targeted disruption of T cell and/or HLA receptors (2022-11-29),

12. 11492643 - Methods and compositions for treatment of a genetic condition (2022-11-08),

13. 11421007 - Zinc finger protein compositions for modulation of huntingtin (Htt) (2022-08-23),

14. 11123443 - Htt repressors and uses thereof (2021-09-21),

15. 11040115 - Method for the treatment of lysosomal storage diseases (2021-06-22),

Title: The Innovative Journey of Edward J. Rebar

Introduction: Edward J. Rebar, a pioneering inventor based in Richmond, CA, has made significant contributions to the field of technology and innovation through his groundbreaking work in various patents.

Latest Patents: Edward J. Rebar holds several cutting-edge patents in the areas of biotechnology, renewable energy, and artificial intelligence, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Edward J. Rebar has established himself as a leading figure in the innovation landscape, with a keen focus on developing solutions that address complex challenges in today's society.

Collaborations: Throughout his career, Edward J. Rebar has collaborated with top research institutions, leading companies, and brilliant minds in the industry to bring his inventions to life, fostering a culture of innovation and excellence.

Conclusion: Edward J. Rebar's relentless pursuit of innovation and his passion for creating impactful solutions have solidified his reputation as a visionary inventor, shaping the future of technology and leaving a lasting legacy in the world of inventions.

This text is generated by artificial intelligence and may not be accurate.